Dockets: 2006P-0224: Take Appropriate Remedial Action Against the Apparent Misbranding of Generic Azithromycin Marketed by Pliva, Inc.

U.S. Food and Drug Administration

horizonal rule

Dockets Management

2006P-0224: Take Appropriate Remedial Action Against the Apparent Misbranding of Generic Azithromycin Marketed by Pliva, Inc.

		Document #			Received Date							Filed Date			Submitter Code					Submitter				FR Date		FR Page						Comment Date						Files			Remarks


		CP1			05/26/2006							05/26/2006			Drug Industry					Pfizer Inc.																			Table of Contents
																				Signature:		Jeffrey Chasnow

		ACK1			05/26/2006							05/26/2006			Federal Government					FDA/DDM to Pfizer Inc.																			pdf
																				Signature:		Lyle D. Jaffe

		EC1			06/27/2006							06/17/2006			Individual Consumer					Mr. D Lowe																			htm Attachment

		EC2			06/27/2006							06/26/2006			Individual Consumer					Mr. Dave Lowe																			htm Attachment

		EC3			06/29/2006							06/27/2006			Individual Consumer					Mr. Dave Lowe																			htm Attachment

Page last updated July 27, 2006 kk horizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management